Standard InChI: InChI=1S/C20H16FN3O4/c21-13-7-11-16-19(17(13)23-6-5-10(22)8-23)28-15-4-2-1-3-14(15)24(16)9-12(18(11)25)20(26)27/h1-4,7,9-10H,5-6,8,22H2,(H,26,27)/t10-/m0/s1
Standard InChI Key: OLNJLTFSGFZCKE-JTQLQIEISA-N
Associated Targets(Human)
DNA topoisomerase II 1334 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MDA-MB-231 73002 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
NCI-H226 44470 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HT-29 80576 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Raji 5516 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
DU-145 51482 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HeLa 62764 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MCF7 126967 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
NCI-H520 551 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
RPMI-8226 44974 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
U-937 7138 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Granta 22 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MIA PaCa-2 5949 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
B16 5829 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 381.36
Molecular Weight (Monoisotopic): 381.1125
AlogP: 2.47
#Rotatable Bonds: 2
Polar Surface Area: 97.79
Molecular Species: ZWITTERION
HBA: 6
HBD: 2
#RO5 Violations: 0
HBA (Lipinski): 7
HBD (Lipinski): 3
#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.24
CX Basic pKa: 9.63
CX LogP: -0.26
CX LogD: -0.26
Aromatic Rings: 3
Heavy Atoms: 28
QED Weighted: 0.55
Np Likeness Score: -0.36
References
1.Kim MY, Na Y, Vankayalapati H, Gleason-Guzman M, Hurley LH.. (2003) Design, synthesis, and evaluation of psorospermin/quinobenzoxazine hybrids as structurally novel antitumor agents., 46 (14):[PMID:12825936][10.1021/jm030096i]
2.Zeng Q, Kwok Y, Kerwin SM, Mangold G, Hurley LH.. (1998) Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model., 41 (22):[PMID:9784102][10.1021/jm980265c]
3.Kim MY, Duan W, Gleason-Guzman M, Hurley LH.. (2003) Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes., 46 (4):[PMID:12570378][10.1021/jm0203377]
4.Xu H, Hurley LH.. (2022) A first-in-class clinical G-quadruplex-targeting drug. The bench-to-bedside translation of the fluoroquinolone QQ58 to CX-5461 (Pidnarulex)., 77 [PMID:36195286][10.1016/j.bmcl.2022.129016]